OSI PHARMACEUTICALS INC
10-K, EX-27, 2000-12-19
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: OSI PHARMACEUTICALS INC, 10-K, EX-23, 2000-12-19
Next: SWISS ARMY BRANDS INC, SC 13D/A, 2000-12-19



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1
<CURRENCY> US DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          SEP-30-2000
<PERIOD-START>                             OCT-01-1999
<PERIOD-END>                               SEP-30-2000
<EXCHANGE-RATE>                                      1
<CASH>                                      48,392,635
<SECURITIES>                                36,672,036
<RECEIVABLES>                                  314,324
<ALLOWANCES>                                    27,289
<INVENTORY>                                          0
<CURRENT-ASSETS>                            87,279,266
<PP&E>                                      24,883,970
<DEPRECIATION>                              15,618,965
<TOTAL-ASSETS>                              99,776,008
<CURRENT-LIABILITIES>                        7,175,043
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       282,819
<OTHER-SE>                                  89,598,810
<TOTAL-LIABILITY-AND-EQUITY>                99,776,008
<SALES>                                        600,912
<TOTAL-REVENUES>                            28,651,428
<CGS>                                          834,870
<TOTAL-COSTS>                               52,264,600
<OTHER-EXPENSES>                               217,531
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              32,268
<INCOME-PRETAX>                           (16,347,569)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (16,347,569)
<EPS-BASIC>                                     (0.67)
<EPS-DILUTED>                                   (0.67)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission